Overview


According to FutureWise analysis, the market for Structural Heart Devices in 2023 is US$ 13.36 billion, and is expected to reach US$ 30.18 billion by 2031 at a CAGR of 10.70%.

Structural heart devices refer to medical devices that are designed to treat abnormalities or defects in the structure of the heart. These devices are used to replace or repair heart valves, repair the heart's hole, and provide support to weakened or damaged areas of the heart. Structural heart devices can be used to treat a wide range of conditions, including congenital heart defects, valvular heart disease, and heart failure. They are typically implanted or delivered via minimally invasive procedures, and they may be permanent or temporary depending on the specific device and condition being treated.

One common type of structural heart device is the heart valve replacement or repair device. These devices are used to replace or repair damaged heart valves, which can occur due to age-related wear and tear, infection, or congenital abnormalities. Some heart valve replacement devices are mechanical, while others are made from biological materials. Valve repair devices are used to reshape or reinforce existing valves rather than replace them entirely. Another type of structural heart device is the closure device. These devices are used to close holes in the heart, such as atrial septal defects or patent foramen ovale. Closure devices are typically delivered via catheterization and are designed to remain in place permanently. Structural heart devices may also be used to provide support to weakened or damaged areas of the heart. For example, left ventricular assist devices (LVADs) are used to support the function of the left ventricle in patients with severe heart failure.

FutureWise Market Research has published a report that provides an insightful analysis of Structural Heart Devices Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Structural Heart Devices Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.
  • Medtronic plc
  • St. Jude Medical, Inc.
  • Braile Biomedica
  • Medical Technology Est.
  • Boston Scientific Corporation
  • Micro Interventional Devices, Inc.
  • Edwards Lifesciences Corporation
  • LivaNova PLC
  • JenaValve Technology, Inc.
  • Cryolife, Inc.
  • Corvia Medical, Inc.
  • CardioKinetix, Inc.
  • Biomerics, LLC
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • XELTIS BV
  • Comed B.V.

Recent developments by key players in Structural Heart Devices Market:

  • In May 2022, Philips unveiled EchoNavigator 4.0, the latest version of their image-guided therapy system to address structural heart disease. With EchoNavigator 4.0, Philips' EPIQ CVXi interventional cardiology ultrasound device users may manage real-time fusion imaging on the company's "Azurion - platform" image-guided therapy system.

The structural heart devices market has been experiencing significant growth in recent years, driven by various factors such as the rising frequency of structural heart diseases, technological advancements in device design, and increasing demand for minimally invasive procedures. Structural heart diseases, such as patent foramen ovale, atrial septal defects, and valvular heart disease, are increasingly common, especially among the aging population. Thus, there is a growing demand for innovative treatment options that can enhance patient outcomes and quality of life. Technological advancements in device design have also contributed to the growth of the market. Structural heart devices have become more sophisticated, with improved features such as increased durability and biocompatibility. These devices are also being designed to be more minimally invasive, reducing the risk of complications and allowing for quicker recovery times. Furthermore, the increasing demand for minimally invasive procedures has driven the development of new structural heart devices such as transcatheter aortic valve replacement and transcatheter mitral valve repair (TMVR). These procedures are less invasive than traditional open-heart surgery, which has led to a significant increase in their adoption. In addition, favorable reimbursement policies and the availability of skilled healthcare professionals have also contributed to the growth of the market. These factors have made structural heart device procedures more accessible to patients, leading to increased adoption rates.

However, the market also faces certain barriers, such as high costs associated with structural heart devices and procedures. This has limited the adoption of these devices in certain regions, especially in developing countries. Additionally, the regulatory environment surrounding the approval of these devices can also be challenging, leading to delays in market entry.

By Product

  • Repair Devices
    • Annuloplasty Rings
    • Heart Valve Balloons
    • Occluders
  • Replacement Valves
    • Mechanical Heart Valves
    • Tissue Heart Valves

By Indication  

  • Atrial Septal Defect (ASD)
  • Ventricular Septal Defect (VSD)
  • Patent Foramen Ovale (PFO)
  • Aortic Valve Stenosis
  • Others

By Age Group

  • Pediatric
    • Infants (6 months to 12 months)
    • Toddlers (1-2 years)
    • New Born (0-5 months)
    • Preschooler (3-5 years)
    • School-aged Children (6-12 years)
    • Adolescent (13-18 years)
  • Adults
    • Young Adults (19-24 years)
    • Adulthood (25-39 years)
    • Middle-aged Persons (40-59 years)
    • Older People/Old Age (60-84 years)
    • Very Old (85+ years)

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. The North American market for structural heart devices is indeed significant, driven by several factors, including the high prevalence of cardiovascular disease, a well-established healthcare infrastructure, and a growing aging population. The U.S., in particular, is the largest market for structural heart devices in North America, accounting for a significant global market share. The demand for structural heart devices in North America is evaluated to grow in the coming years due to the increasing incidence of heart disease and the development of innovative technologies. Structural heart devices, such as transcatheter heart valves and left atrial appendage closure devices, are among the most promising and fast-growing segments of the market.


  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Structural Heart Devices Market By Product, By Indication, By Age Group and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches.
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Structural Heart Devices Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Structural Heart Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Structural Heart Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Structural Heart Devices Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Repair Devices
         1.1. Annuloplasty Rings
         1.2. Heart Valve Balloons
         1.3. Occluders
        2. Replacement Valves
         2.1. Mechanical Heart Valves
         2.2. Tissue Heart Valves

  • 8.   Structural Heart Devices Market, By Indication Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Atrial Septal Defect (ASD)
        2. Ventricular Septal Defect (VSD)
        3. Patent Foramen Ovale (PFO)
        4. Aortic Valve Stenosis
        5. Others

  • 9.   Structural Heart Devices Market, By Age Group Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Pediatric
         1.1. Infants (6 months to 12 months)
         1.2. Toddlers (1-2 years)
         1.3. New Born (0-5 months)
         1.4. Preschooler (3-5 years)
         1.5. School-aged Children (6-12 years)
         1.6. Adolescent (13-18 years)
        2. Adults
         2.1. Young Adults (19-24 years)
         2.2. Adulthood (25-39 years)
         2.3. Middle-aged Persons (40-59 years)
         2.4. Older People/Old Age (60-84 years)
         2.5. Very Old (85+ years)

  • 10.   North America Structural Heart Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Structural Heart Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Structural Heart Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Structural Heart Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Structural Heart Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Medtronic plc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. St. Jude Medical, Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Braile Biomedica
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Medical Technology Est.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Boston Scientific Corporation
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Micro Interventional Devices, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Edwards Lifesciences Corporation
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. LivaNova PLC
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. JenaValve Technology, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Cryolife, Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Corvia Medical, Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. CardioKinetix, Inc.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Biomerics, LLC
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Lepu Medical Technology (Beijing) Co., Ltd.
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. XELTIS BV
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Comed B.V.
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11